Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118481272 | 11848127 | 2 | F | 201511 | 20160720 | 20151217 | 20160727 | PER | US-PFIZER INC-2015442821 | PFIZER | 63.00 | YR | M | Y | 92.00000 | KG | 20160727 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118481272 | 11848127 | 1 | PS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | UNK | N | UNK | 62911 | |||||||||
| 118481272 | 11848127 | 2 | C | NOVOLIN | INSULIN HUMAN | 1 | Subcutaneous | 16 IU, 1X/DAY | 0 | 16 | IU | QD | |||||||
| 118481272 | 11848127 | 3 | C | NOVOLIN | INSULIN HUMAN | 1 | Subcutaneous | 18 IU, 1X/DAY | 0 | 18 | IU | QD | |||||||
| 118481272 | 11848127 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | QD | |||||||
| 118481272 | 11848127 | 5 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 118481272 | 11848127 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | BID | |||||||
| 118481272 | 11848127 | 7 | C | DICLOFENAC | DICLOFENAC | 1 | Topical | 1 %, AS NEEDED | 0 | 1 | PCT | GEL | |||||||
| 118481272 | 11848127 | 8 | C | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | 1 DF, AS NEEDED | 0 | 1 | DF | OINTMENT | ||||||||
| 118481272 | 11848127 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 118481272 | 11848127 | 10 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, AS NEEDED | 0 | 25 | MG | ||||||||
| 118481272 | 11848127 | 11 | C | WARFARIN | WARFARIN | 1 | Oral | 5 MG, X 1 WEEK | 0 | 5 | MG | /wk | |||||||
| 118481272 | 11848127 | 12 | C | WARFARIN | WARFARIN | 1 | 7.5 MG, 6X/WEEK | 0 | 7.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118481272 | 11848127 | 1 | Wound infection staphylococcal |
| 118481272 | 11848127 | 2 | Type 2 diabetes mellitus |
| 118481272 | 11848127 | 4 | Atrial fibrillation |
| 118481272 | 11848127 | 5 | Hypertension |
| 118481272 | 11848127 | 6 | Cardiac failure congestive |
| 118481272 | 11848127 | 7 | Osteoarthritis |
| 118481272 | 11848127 | 8 | Blepharitis |
| 118481272 | 11848127 | 9 | Hyperlipidaemia |
| 118481272 | 11848127 | 10 | Cardiac failure congestive |
| 118481272 | 11848127 | 11 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118481272 | 11848127 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118481272 | 11848127 | Acute kidney injury | |
| 118481272 | 11848127 | Drug ineffective | |
| 118481272 | 11848127 | Staphylococcal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118481272 | 11848127 | 1 | 201511 | 201511 | 0 | |
| 118481272 | 11848127 | 2 | 2011 | 0 | ||
| 118481272 | 11848127 | 3 | 2011 | 0 | ||
| 118481272 | 11848127 | 4 | 2004 | 0 | ||
| 118481272 | 11848127 | 5 | 2004 | 20151128 | 0 | |
| 118481272 | 11848127 | 6 | 20110101 | 0 | ||
| 118481272 | 11848127 | 7 | 2011 | 0 | ||
| 118481272 | 11848127 | 8 | 20110101 | 0 | ||
| 118481272 | 11848127 | 9 | 2008 | 0 | ||
| 118481272 | 11848127 | 10 | 2011 | 20151128 | 0 | |
| 118481272 | 11848127 | 11 | 1995 | 0 | ||
| 118481272 | 11848127 | 12 | 1995 | 0 |